Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.117014 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Xueqin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, …. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Neoplasm Recurrence, Local. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Shanghai Clinical Research C…
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Head & Neck Medical Oncology, Fudan University Shanghai Cancer, Shanghai, China.
Zitieren
APA
Chen, X., Zhu, L., Chen, J., Qian, W., Liu, P., Xu, T., Shen, C., Ji, D., Hu, C., Lu, X., & Zhou, X. (2026). Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117014
Vancouver
Chen X, Zhu L, Chen J, Qian W, Liu P, Xu T, et al. Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.117014
BibTeX
@article{Chen2026,
author = {Chen, Xueqin and Zhu, Lin and Chen, Jie and Qian, Wei and Liu, Peiyao and Xu, Tingting and Shen, Chunying and Ji, Dongmei and Hu, Chaosu and Lu, Xueguan and Zhou, Xin},
title = {Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.117014}
}
EUVIMED